Home
    • Plans Blog Contact
    Arcadia Biosciences Inc logo

    Arcadia Biosciences Inc

    RKDA
    Last price US$0.641
    Market cap US$1.3m
    12M price change N/A
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    General Mills IncGIS Industry peer Ingredion IncINGR Industry peer FLOWERS FOODS INCFLO Industry peer Hershey CoHSY Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Arcadia Biosciences Inc Overview

    Industry: Packaged Foods

    Sector: Consumer Defensive

    Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, be Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Arcadia Biosciences Inc into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed May 14, 2026

    Quarterly result summary

    Revenue was $1.1M (-8% YoY).

    Revenue $1.1M -8% YoY

    What changed

    • Revenue -8% YoY to $1.1M.

    Guidance / outlook

    we expect to be on the shelves of many of our largest customers this fall,” Schaefer added.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q May 14, 2026 SEC filing 8-K May 14, 2026 SEC filing 10-K/A Apr 30, 2026 SEC filing 10-K Mar 26, 2026 SEC filing 8-K Mar 26, 2026 Earnings release Earnings release Mar 26, 2026 SEC filing 8-K Nov 07, 2025 SEC filing 10-Q Nov 07, 2025 Earnings release Earnings release Nov 07, 2025 SEC filing 10-Q Aug 14, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    No qualified company news in the last 14 days

    No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.

    Earnings Per Share

    Score 4.00/5
    Arcadia Biosciences Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Hershey Co Procter & Gamble Company Grand Canyon Education Inc
    In Packaged Foods industry , General Mills Inc , Ingredion Inc , FLOWERS FOODS INC are companies with high ratings.

    Return on Equity

    Score 0.27/5
    Arcadia Biosciences Inc exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Hershey Co Procter & Gamble Company Grand Canyon Education Inc
    Arcadia Bios... RKDA US$1.3m
    Hershey Co HSY US$36.9b
    Procter & Ga... PG US$343.4b
    Grand Canyon... LOPE US$4.0b

    Net Margin

    Score 0.32/5
    Arcadia Biosciences Inc olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Hershey Co Procter & Gamble Company Grand Canyon Education Inc
    Arcadia Bios... RKDA US$1.3m
    Hershey Co HSY US$36.9b
    Procter & Ga... PG US$343.4b
    Grand Canyon... LOPE US$4.0b

    Share Buyback

    In Packaged Foods industry , General Mills Inc , Ingredion Inc , FLOWERS FOODS INC are companies with high ratings.

    Leverage

    Score 3.11/5
    Arcadia Biosciences Inc attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Hershey Co Procter & Gamble Company Grand Canyon Education Inc , also exhibit high scores.
    Arcadia Bios... RKDA US$1.3m
    Hershey Co HSY US$36.9b
    Procter & Ga... PG US$343.4b
    Grand Canyon... LOPE US$4.0b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Arcadia Biosciences Inc logo

    Arcadia Biosciences Inc

    US$0.641

    US$1.3m

    -4.33%

    N/A